Effectiveness and cost-effectiveness of traditional and new partner notification technologies for curable sexually transmitted infections: Observational study, systematic reviews and mathematical modelling

Health Technology Assessment

Volumn 18, Issue 2, 2014, Pages 1-99

  Althaus, Christian L ^a   Turner, Katherine M E ^b   Mercer, Catherine H ^c   Auguste, Peter ^d   Roberts, Tracy E ^d   Bell, Gill ^e   Herzog, Sereina A ^a   Cassell, Jackie A ^f   Edmunds, W John ^g   White, Peter J ^h,i   Ward, Helen ⁱ   Low, Nicola ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY OF BRIGHTON   (United Kingdom)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^h PUBLIC HEALTH ENGLAND   (United Kingdom)

ⁱ IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; ECONOMIC ASPECT; EVIDENCE BASED PRACTICE; GONORRHEA; HEALTH CARE COST; HEALTH CARE POLICY; HETEROSEXUALITY; HUMAN; INFORMATION; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; OBSERVATIONAL STUDY; PARTNER NOTIFICATION; PATIENT REFERRAL; PREVALENCE; QUALITY OF LIFE; REINFECTION; SCREENING; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SYPHILIS;

ADOLESCENT; ADULT; CONTACT TRACING; COST-BENEFIT ANALYSIS; FEMALE; GREAT BRITAIN; HUMANS; MALE; MODELS, BIOLOGICAL; MODELS, STATISTICAL; QUALITY-ADJUSTED LIFE YEARS; RECURRENCE; SEXUALLY TRANSMITTED DISEASES; STATE MEDICINE; YOUNG ADULT;

EID: 84892612450     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta18020     Document Type: Article

References (136)

1. WHO/UNAIDS. Sexually Transmitted Diseases: Policies and Principles for Prevention and Care. Geneva: UNAIDS, UNAIDS Best Practice Collection; 1999. pp. 1-47.
2. World Health Organization. Global Strategy for the Prevention and Control of Sexually Transmitted Infections: 2006-2015. 2007. URL: http://whqlibdoc.who.int/publications/2007/9789241563475_eng.pdf (cited 2 November 2012).
3. Golden MR, Faxelid E, Low N. Partner notification for sexually transmitted infections including HIV infection: an evidence-based assessment. In Holmes KK, Sparling PF, Stamm WE, Piot P, Wasserheit JN, Corey L, et al., editors. Sexually Transmitted Diseases. 4th edn. New York, NY: McGraw-Hill; 2008. pp. 965-84.
4. Low N, Broutet N, Adu-Sarkodie Y, Barton P, Hossain M, Hawkes S. Global control of sexually transmitted infections. Lancet 2006;368:2001-16. http://dx.doi.org/10.1016/S0140-6736(06)69482-8
5. Wasserheit JN, Aral SO. The dynamic topology of sexually transmitted disease epidemics: implications for prevention strategies. J Infect Dis 1996;174(Suppl. 2):S201-13. http://dx.doi.org/10.1093/infdis/174.Supplement_2.S201
6. Lycke E, Lowhagen GB, Hallhagen G, Johannisson G, Ramstedt K. The risk of transmission of genital Chlamydia trachomatis infection is less than that of genital Neisseria gonorrhoeae infection. Sex Transm Dis 1980;7:6-10. http://dx.doi.org/10.1097/00007435-198001000-00002
7. Quinn TC, Gaydos C, Shepherd M, Bobo L, Hook EW, Viscidi R, et al. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA 1996;276:1737-42. http://dx.doi.org/10.1001/jama.276.21.1737
8. Johnson AM, Mercer CH, Erens B, Copas AJ, McManus S, Wellings K, et al. Sexual behaviour in Britain: partnerships, practices and HIV risk behaviours. Lancet 2001;358:1835-42. http://dx.doi.org/10.1016/S0140-6736(01)06883-0
9. Mercer CH, Aicken CR, Brook MG, Estcourt CS, Cassell JA. Estimating the likely public health impact of partner notification for a clinical service: an evidence-based algorithm. Am J Public Health 2011;101:2117-23. [Erratum published in Am J Public Health 2012;102;e7-8.] http://dx.doi.org/10.2105/AJPH.2011.300211
10. British Association of Sexual Health and HIV Clinical Effectiveness Group. 2006 UK National Guideline for the Management of Genital Tract Infection with Chlamydia trachomatis. URL: www.bashh.org/documents/65.pdf (cited 2 November 2012).
11. Bignell C, FitzGerald M. UK national guideline for the management of gonorrhoea in adults, 2011. Int J STD AIDS 2011;22:541-7. http://dx.doi.org/10.1258/ijsa.2011.011267
12. British Association of Sexual Health and HIV Clinical Effectiveness Group. UK National Guidelines on the Management of Syphilis 2008. 2008. URL: www.bashh.org/documents/1879.pdf (cited 2 November 2012).
13. Golden MR, Whittington WL, Gorbach PM, Coronado N, Boyd MA, Holmes KK. Partner notification for chlamydial infections among private sector clinicians in Seattle-King County: a clinician and patient survey. Sex Transm Dis 1999;26:543-7. http://dx.doi.org/10.1097/00007435-199910000-00011
14. Arthur G, Lowndes CM, Blackham J, Fenton KA. Divergent approaches to partner notification for sexually transmitted infections across the European union. Sex Transm Dis 2005;32:734-41. http://dx.doi.org/10.1097/01.olq.0000175376.62297.73
15. Potterat JJ, Rothenberg R. The case-finding effectiveness of self-referral system for gonorrhea: a preliminary report. Am J Public Health 1977;67:174-6. http://dx.doi.org/10.2105/AJPH.67.2.174
16. Kissinger P, Mohammed H, Richardson-Alston G, Leichliter JS, Taylor SN, Martin DH, et al. Patient-delivered partner treatment for male urethritis: a randomized, controlled trial. Clin Infect Dis 2005;41:623-9. http://dx.doi.org/10.1086/432476
17. Wilson TE, Hogben M, Malka ES, Liddon N, McCormack WM, Rubin SR, et al. A randomized controlled trial for reducing risks for sexually transmitted infections through enhanced patient-based partner notification. Am J Public Health 2009;99(Suppl. 1):S104-10. http://dx.doi.org/10.2105/AJPH.2007.112128
18. Tomnay JE, Pitts MK, Kuo TC, Fairley CK. Does the Internet assist clients to carry out contact tracing? A randomized controlled trial using web-based information. Int J STD AIDS 2006;17:391-4. http://dx.doi.org/10.1258/095646206777323391
19. Cameron ST, Glasier A, Scott G, Young H, Melvin L, Johnstone A, et al. Novel interventions to reduce re-infection in women with chlamydia: a randomized controlled trial. Hum Reprod 2009;24:888-95. http://dx.doi.org/10.1093/humrep/den475
20. Estcourt C, Sutcliffe L, Cassell J, Mercer CH, Copas A, James L, et al. Can we improve partner notification rates through expedited partner therapy in the UK? Findings from an exploratory trial of Accelerated Partner Therapy (APT). Sex Transm Infect 2012;88:21-6. http://dx.doi.org/10.1136/sti.2010.047258
21. Dombrowski JC, Golden MR. Accelerated partner therapy: a promising new partner treatment option. Sex Transm Infect 2012;88:2-3. http://dx.doi.org/10.1136/sextrans-2011-050377
22. Trelle S, Shang A, Nartey L, Cassell JA, Low N. Improved effectiveness of partner notification for patients with sexually transmitted infections: systematic review. BMJ 2007;334:354-7. http://dx.doi.org/10.1136/bmj.39079.460741.7C
23. Centers for Disease Control and Prevention. Expedited Partner Therapy in the Management of Sexually Transmitted Diseases: Review and Guidance. Atlanta, GA: US Department of Health and Human Services; 2006.
24. Health Protection Agency (now Public Health England). STI Annual Data Tables. 2012. URL: www.hpa.org.uk/webw/HPAweb&Page&HPAwebAutoListName/Page/1201094610372#2_STI_data_tables_2011 (cited 20 June 2012).
25. Creighton S, Tenant-Flowers M, Taylor CB, Miller R, Low N. Co-infection with gonorrhoea and chlamydia: how much is there and what does it mean? Int J STD AIDS 2003;14:109-13. http://dx.doi.org/10.1258/095646203321156872
26. Datta SD, Sternberg M, Johnson RE, Berman S, Papp JR, McQuillan G, et al. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med 2007;147:89-96. http://dx.doi.org/10.7326/0003-4819-147-2-200707170-00007
27. Nsuami M, Cammarata CL, Brooks BN, Taylor SN, Martin DH. Chlamydia and gonorrhea co-occurrence in a high school population. Sex Transm Dis 2004;31:424-7. http://dx.doi.org/10.1097/01.OLQ.0000130535.96576.D3
28. Batteiger BE, Tu W, Ofner S, Van Der Pol B, Stothard DR, Orr DP, et al. Repeated Chlamydia trachomatis genital infections in adolescent women. J Infect Dis 2010;201:42-51.
29. Golden M. Washington State Community Expedited Partner Treatment (EPT) Trial. Trial registration, ClinicalTrials.gov.2012. URL: http://clinicaltrials.gov/ct2/show/NCT01665690 (cited 1 November 2012).
30. Low N, Welch J, Radcliffe K. Developing national outcome standards for the management of gonorrhoea and genital chlamydia in genitourinary medicine clinics. Sex Transm Infect 2004;80:223-9. http://dx.doi.org/10.1136/sti.2003.005165
31. Turner K, Adams E, Grant A, Macleod J, Bell G, Clarke J, et al. Costs and cost effectiveness of different strategies for chlamydia screening and partner notification: an economic and mathematical modelling study. BMJ 2011;342:c7250. http://dx.doi.org/10.1136/bmj.c7250
32. Hallett TB, White PJ, Garnett GP. Appropriate evaluation of HIV prevention interventions: from experiment to full-scale implementation. Sex Transm Infect 2007;83 (Suppl. 1):I55-60. http://dx.doi.org/10.1136/sti.2006.023663
33. Barton P, Bryan S, Robinson S. Modelling in the economic evaluation of health care: selecting the appropriate approach. J Health Serv Res Policy 2004;9:110-18. http://dx.doi.org/10.1258/135581904322987535
34. Edmunds WJ, Medley GF, Nokes DJ. Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective. Stat Med 1999;18:3263-82. http://dx.doi.org/10.1002/(SICI)1097-0258(19991215)18:233263::AID-SIM3153.0.CO;2-3
35. Regan DG, Wilson DP, Hocking JS. Coverage is the key for effective screening of Chlamydia trachomatis in Australia. J Infect Dis 2008;198:349-58.
36. Brunham RC, Pourbohloul B, Mak S, White R, Rekart ML. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J Infect Dis 2005;192:1836-44.
37. Garnett GP, Mertz KJ, Finelli L, Levine WC, St Louis ME. The transmission dynamics of gonorrhoea: modelling the reported behaviour of infected patients from Newark, NJ. Phil Trans R Soc Lond B 1999;354:787-97. http://dx.doi.org/10.1098/rstb.1999.0431
38. Kretzschmar M, Van Duynhoven YTHP, Severijnen AJ. Modeling prevention strategies for gonorrhea and chlamydia using stochastic network simulations. Am J Epidemiol 1996;144: 306-17. http://dx.doi.org/10.1093/oxfordjournals.aje.a008926
39. Low N, McCarthy A, Macleod J, Salisbury C, Campbell R, Roberts TE, et al. Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. Health Technol Assess 2007;11(8):97-114.
40. Turner KM, Adams EJ, Gay N, Ghani AC, Mercer C, Edmunds WJ. Developing a realistic sexual network model of chlamydia transmission in Britain. Theor Biol Med Model 2006;3:3.
41. Kretzschmar M, Turner KM, Barton PM, Edmunds WJ, Low N. Predicting the population impact of chlamydia screening programmes: comparative mathematical modelling study. Sex Transm Infect 2009;85:359-66. http://dx.doi.org/10.1136/sti.2009.036251
42. Winter AJ, Sriskandabalan P, Wade AA, Cummins C, Barker P. Sociodemography of genital Chlamydia trachomatis in Coventry, UK, 1992-6. Sex Transm Infect 2000;76:103-9. http://dx.doi.org/10.1136/sti.76.2.103
43. Low N, Sterne JA, Barlow D. Inequalities in rates of gonorrhoea and chlamydia between Black ethnic groups in South East London: cross-sectional study. Sex Transm Infect 2001;77:15-20. http://dx.doi.org/10.1136/sti.77.1.15
44. Ferreira A, Young T, Mathews C, Zunza M, Low N. Strategies for partner notification for sexually transmitted infections, including HIV. Cochrane Database Syst Rev 2013;10:CD002843. http://dx.doi.org/10.1002/14651858.CD002843.pub2
45. Herzog SA, McClean H, Carne CA, Low N. Variation in partner notification outcomes for chlamydia in UK genitourinary medicine clinics: multilevel study. Sex Transm Infect 2011; 87:420-5. http://dx.doi.org/10.1136/sti.2011.049320
46. Althaus CL, Heijne JCM, Roellin A, Low N. Transmission dynamics of Chlamydia trachomatis affect the impact of screening programmes. Epidemics 2010;2:123-31. http://dx.doi.org/10.1016/j.epidem.2010.04.002
47. Althaus CL, Heijne JC, Low N. Towards more robust estimates of the transmissibility of Chlamydia trachomatis. Sex Transm Dis 2012;39:402-4. http://dx.doi.org/10.1097/OLQ.0b013e318248a550
48. Althaus CL, Turner KM, Schmid BV, Heijne JC, Kretzschmar M, Low N. Transmission of Chlamydia trachomatis through sexual partnerships: a comparison between three individual-based models and empirical data. J R Soc Interface 2012;9:136-46. http://dx.doi.org/10.1098/rsif.2011.0131
49. Althaus CL, Heijne JCM, Herzog SA, Roellin A, Low N. Individual and population level effects of partner notification for Chlamydia trachomatis. PLOS ONE 2012;7:e51438. http://dx.doi.org/10.1371/journal.pone.0051438
50. Mathews C, Coetzee N, Zwarenstein M, Lombard C, Guttmacher S, Oxman A, et al. Strategies for partner notification for sexually transmitted diseases. Cochrane Database Syst Rev 2001;4: CD002843. http://dx.doi.org/10.1002/14651858.CD002843
51. Golden MR, Whittington WL, Handsfield HH, Hughes JP, Stamm WE, Hogben M, et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med 2005;352:676-85. http://dx.doi.org/10.1056/NEJMoa041681
52. Schillinger JA, Kissinger P, Calvet H, Whittington WL, Ransom RL, Sternberg MR, et al. Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis 2003;30:49-56. http://dx.doi.org/10.1097/00007435-200301000-00011
53. Kissinger P, Schmidt N, Mohammed H, Leichliter JS, Gift TL, Meadors B, et al. Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trial. Sex Transm Dis 2006;33:445-50. http://dx.doi.org/10.1097/01.olq.0000204511.84485.4c
54. Schwebke JR, Desmond RA. A randomized controlled trial of partner notification methods for prevention of trichomoniasis in women. Sex Transm Dis 2010;37:392-6. http://dx.doi.org/10.1097/OLQ.0b013e3181dd1691
55. Low N, McCarthy A, Roberts TE, Huengsberg M, Sanford E, Sterne JAC, et al. Partner notification for chlamydia in primary care: randomised controlled trial and analysis of resource use. BMJ 2006;332:14-19. http://dx.doi.org/10.1136/bmj.38678.405370.7C
56. Kerani RP, Fleming M, DeYoung B, Golden MR. A randomized, controlled trial of inSPOT and patient-delivered partner therapy for gonorrhea and chlamydial infection among men who have sex with men. Sex Transm Dis 2011;38:941-6. http://dx.doi.org/10.1097/OLQ.0b013e318223fcbc
57. Nuwaha F, Kambugu F, Nsubuga PS, Hojer B, Faxelid E. Efficacy of patient-delivered partner medication in the treatment of sexual partners in Uganda. Sex Transm Dis 2001;28:105-10. http://dx.doi.org/10.1097/00007435-200102000-00008
58. Katz BP, Danos CS, Quinn TS, Caine V, Jones RB. Efficiency and cost-effectiveness of field follow-up for patients with Chlamydia trachomatis infection in a sexually transmitted diseases clinic. Sex Transm Dis 1988;15:11-16.
59. Moyo W, Chirenje ZM, Mandel J, Schwarcz SK, Klausner J, Rutherford G, et al. Impact of a single session of counseling on partner referral for sexually transmitted disease treatment, Harare, Zimbabwe. AIDS Behav 2002;6:237-43.
60. Solomon MZ, DeJong W. The impact of a clinic-based educational videotape on knowledge and treatment behavior of men with gonorrhea. Sex Transm Dis 1988;15:127-32. http://dx.doi.org/10.1097/00007435-198807000-00001
61. Trent M, Chung SE, Burke M, Walker A, Ellen JM. Results of a randomized controlled trial of a brief behavioral intervention for pelvic inflammatory disease in adolescents. J Pediatr Adolesc Gynecol 2010;23:96-101. http://dx.doi.org/10.1016/j.jpag.2009.06.005
62. Montesinos L, Frisch LE, Greene BF, Hamilton M. An analysis of and intervention in the sexual transmission of disease. J Appl Behavr Anal 1990;23:275-84. http://dx.doi.org/10.1901/jaba.1990.23-275
63. Andersen B, Ostergaard L, Moller JK, Olesen F. Home sampling versus conventional contact tracing for detecting Chlamydia trachomatis infection in male partners of infected women: randomised study. BMJ 1998;316:350-1. http://dx.doi.org/10.1136/bmj.316.7128.350
64. Apoola A, Beardsley J. Does the addition of a urine testing kit to use of contact slips increase the partner notification rates for genital chlamydial infection? Int J STD AIDS 2009;20:775-7. http://dx.doi.org/10.1258/ijsa.2009.009196
65. Ostergaard L, Andersen B, Moller JK, Olesen F, Worm AM. Managing partners of people diagnosed with Chlamydia trachomatis: a comparison of two partner testing methods. Sex Transm Infect 2003;79:358-61. http://dx.doi.org/10.1136/sti.79.5.358
66. Carne C, McClean H, Bhaduri S, Bunting P, Fernandes A, Dhar J, et al. UK National Audit of chlamydial infection management in sexual health clinics. Clinic policies audit. Int J STD AIDS 2008;19:477-9. http://dx.doi.org/10.1258/ijsa.2008.008139
67. McClean H, Carne C, Bunting P, Bhaduri S, Fernandes A, Dhar J, et al. UK National Audit of chlamydial infection management in sexual health clinics. Case notes audit: information-giving, partner notification and follow-up. Int J STD AIDS 2008;19:473-6. http://dx.doi.org/10.1258/ijsa.2008.008138
68. McClean H, Carne C, Bunting P, Bhaduri S, Fernandes A, Dhar J, et al. UK National Audit of chlamydial infection management in sexual health clinics. Case notes audit: demography, diagnosis and treatment. Int J STD AIDS 2008;19:469-72. http://dx.doi.org/10.1258/ijsa.2008.008137
69. Berwick DM. Controlling variation in health care: a consultation from Walter Shewhart. Med Care 1991;29:1212-25. http://dx.doi.org/10.1097/00005650-199112000-00004
70. Hoaglin DC. Understanding Robust and Explanatory Data Analysis. New York, NY: Wiley & Sons; 2000.
71. Twisk JWR. Applied Multilevel Analysis: A Practical Guide. Cambridge: Cambridge University Press; 2006.
72. Rogstad KE, Clementson C, Ahmed-Jushuf IH. Contact tracing for gonorrhoea in homosexual and heterosexual men. Int J STD AIDS 1999;10:536-8. http://dx.doi.org/10.1258/0956462991914636
73. Society for Sexual Health Advisers. The SSHA Manual for Sexual Health Advisers. URL: www.ssha.info/resources/manual-for-sexual-health-advisers/2004 (cited 20 December 2010).
74. Richards S. Should the NHS strive to eradicate all unexplained variation? Yes. BMJ 2009;339:1172-3. http://dx.doi.org/10.1136/bmj.b4811
75. Lilford RJ. Should the NHS strive to eradicate all unexplained variation? No. BMJ 2009; 339:1172-3. http://dx.doi.org/10.1136/bmj.b4809
76. Fenton KA, Mercer CH, Johnson AM, Byron CL, McManus S, Erens B, et al. Reported sexually transmitted disease clinic attendance and sexually transmitted infections in Britain: prevalence, risk factors, and proportionate population burden. J Infect Dis 2005;191 (Suppl. 1):S127-38. http://dx.doi.org/10.1086/425286
77. Fenton KA, Korovessis C, Johnson AM, McCadden A, McManus S, Wellings K, et al. Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet 2001;358:1851-4. http://dx.doi.org/10.1016/S0140-6736(01)06886-6
78. Mercer CH, Copas AJ, Sonnenberg P, Johnson AM, McManus S, Erens B, et al. Who has sex with whom? Characteristics of heterosexual partnerships reported in a national probability survey and implications for STI risk. Int J Epidemiol 2009;38:206-14. http://dx.doi.org/10.1093/ije/dyn216
79. Cassell JA, Mercer CH, Imrie J, Copas AJ, Johnson AM. Who uses condoms with whom? Evidence from national probability sample surveys. Sex Transm Infect 2006;82:467-73. http://dx.doi.org/10.1136/sti.2005.019117
80. Last JM. A Dictionary of Epidemiology. Oxford: Oxford University Press; 2001.
81. Howard MM, Fortenberry JD, Blythe MJ, Zimet GD, Orr DP. Patterns of sexual partnerships among adolescent females. J Adolesc Health 1999;24:300-3. http://dx.doi.org/10.1016/S1054-139X(98)00145-1
82. Garnett GP, Hughes JP, Anderson RM, Stoner BP, Aral SO, Whittington WL, et al. Sexual mixing patterns of patients attending sexually transmitted diseases clinics. Sex Transm Dis 1996;23:248-57. http://dx.doi.org/10.1097/00007435-199605000-00015
83. Bell G, Ward H, Day S, Ghani AC, Goan U, Claydon E, et al. Partner notification for gonorrhoea: a comparative study with a provincial and a metropolitan UK clinic. Sex Transm Infect 1998;74:409-14. http://dx.doi.org/10.1136/sti.74.6.409
84. Kretzschmar M, Welte R, van Den HA, Postma MJ. Comparative model-based analysis of screening programs for chlamydia trachomatis infections. Am J Epidemiol 2001;153:90-101. http://dx.doi.org/10.1093/aje/153.1.90
85. Molano M, Meijer CJ, Weiderpass E, Arslan A, Posso H, Franceschi S, et al. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. J Infect Dis 2005;191:907-16.
86. Katz BP. Estimating transmission probabilities for chlamydial infection. Stat Med 1992;11:565-77. http://dx.doi.org/10.1002/sim.4780110502
87. Garnett GP, Bowden FJ. Epidemiology and control and curable sexually transmitted diseases: opportunities and problems. Sex Transm Dis 2000;27:588-99. http://dx.doi.org/10.1097/00007435-200011000-00007
88. Heijne JCM, Althaus CL, Herzog SA, Kretzschmar M, Low N. The role of reinfection and partner notification in the efficacy of Chlamydia screening programs. J Infect Dis 2011;203:372-7. http://dx.doi.org/10.1093/infdis/jiq050
89. Dietz K, Hadeler KP. Epidemiological models for sexually transmitted diseases. J Math Biol 1988;26:1-25. http://dx.doi.org/10.1007/BF00280169
90. Kretzschmar M, Jager JC, Reinking DP, Van Zessen G, Brouwers H. The basic reproduction ratio R0 for a sexually transmitted disease in a pair formation model with two types of pairs. Math Biosci 1994;124:181-205. http://dx.doi.org/10.1016/0025-5564(94)90042-6
91. Powers KA, Ghani AC, Miller WC, Hoffman IF, Pettifor AE, Kamanga G, et al. The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet 2011;378:256-68. http://dx.doi.org/10.1016/S0140-6736(11)60842-8
92. Bolker BM. Ecological Models and Data in R. Princeton, NJ: Princeton University Press; 2008.
93. Welte R, Postma M, Leidl R, Kretzschmar M. Costs and effects of chlamydial screening: dynamic versus static modeling. Sex Transm Dis 2005;32:474-83. http://dx.doi.org/10.1097/01.olq.0000161181.48687.cf
94. Johnson LF, Alkema L, Dorrington RE. A Bayesian approach to uncertainty analysis of sexually transmitted infection models. Sex Transm Infect 2010;86:169-74. http://dx.doi.org/10.1136/sti.2009.037341
95. Tu W, Ghosh P, Katz BP. A stochastic model for assessing Chlamydia trachomatis transmission risk using longitudinal observational data. J R Stat Soc Ser A Stat Soc 2011;174:975-89. http://dx.doi.org/10.1111/j.1467-985X.2011.00691.x
96. Brunham RC, Rey-Ladino J. Immunology of chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol 2005;5:149-61. http://dx.doi.org/10.1038/nri1551
97. Brunham RC, Rekart ML. The arrested immunity hypothesis and the epidemiology of chlamydia control. Sex Transm Dis 2008;35:53-4. http://dx.doi.org/10.1097/OLQ.0b013e31815e41a3
98. Regan DG, Wilson DP. Modelling sexually transmitted infections: less is usually more for informing public health policy. Trans R Soc Trop Med Hyg 2008;102:207-8. http://dx.doi.org/10.1016/j.trstmh.2007.08.009
99. Carré H, Boman J, Osterlund A, Garden B, Nylander E. Improved contact tracing for Chlamydia trachomatis with experienced tracers, tracing for one year back in time and interviewing by phone in remote areas. Sex Transm Infect 2008;84:239-42. http://dx.doi.org/10.1136/sti.2007.028068
100. Zimmerman-Rogers H, Potterat JJ, Muth SQ, Bonney MS, Green DL, Taylor JE, et al. Establishing efficient partner notification periods for patients with chlamydia. Sex Transm Dis 1999;26:49-54. http://dx.doi.org/10.1097/00007435-199901000-00008
101. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2010. MMWR 2010;59:44-5. URL: www.cdc.gov/std/treatment/2010/STD-Treatment-2010-RR5912.pdf
102. Dietz K, Tudor D. Triangles in heterosexual HIV transmission. In Jewell NP, Kietz K, Farewell VT, editors. AIDS Epidemiology. Boston, MA: Birkhäuser; 1992. pp. 143-55.
103. Johnson AM, Mercer CH, Erens B, Copas AJ, McManus S, Wellings K, et al. Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet 2001;358:1835-42. http://dx.doi.org/10.1016/S0140-6736(01)06883-0
104. Kretzschmar M, Satterwhite C, Leichliter J, Berman S. Effects of screening and partner notification on chlamydia positivity in the United States: a modeling study. Sex Transm Dis 2012;39:325-31. http://dx.doi.org/10.1097/OLQ.0b013e31824e52c2
105. Armbruster B, Brandeau ML. Contact tracing to control infectious disease: when enough is enough. Health Care Manag Sci 2007;10:341-55. http://dx.doi.org/10.1007/s10729-007-9027-6
106. Turner KME. Mathematical Models of Gonorrhoea and Chlamydia: Biology, Behaviour and Interventions. PhD thesis. London: Imperial College London; 2004.
107. Stupiansky NW, Van der Pol B, Williams JA, Weaver B, Taylor SE, Fortenberry JD. The natural history of incident gonococcal infection in adolescent women. Sex Transm Dis 2011;38:750-4. http://dx.doi.org/10.1097/OLQ.0b013e31820ff9a4
108. Vonck RA, Darville T, O'Connell CM, Jerse AE. Chlamydial infection increases gonococcal colonization in a novel murine coinfection model. Infect Immun 2011;79:1566-77. http://dx.doi.org/10.1128/IAI.01155-10
109. Hethcote HW, Yorke JA. Gonorrhea transmission dynamics and control. Lecture Notes in Biomathematics 1984;56:1-53.
110. Batteiger BE, Xu F, Johnson RE, Rekart ML. Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies. J Infect Dis 2010;201(Suppl. 2):S178-89.
111. Brook MG, Rusere L, Coppin-Browne L, McDonagh S, McSorley J. A prospective study of the effectiveness of electronic patient records in rapid-cycle assessment of treatment and partner notification outcomes for patients with genital chlamydia and gonorrhoea infection. Sex Transm Infect 2011;87:152-5. http://dx.doi.org/10.1136/sti.2010.042440
112. Roberts TE, Robinson S, Barton P, Bryan S, Low N. Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling. Sex Transm Infect 2006; 82:193-200. http://dx.doi.org/10.1136/sti.2005.017517
113. Postma MJ, Welte R, Van den Hoek JAR, Van Doornum GJJ, Jager HC, Coutinho RA. Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia trachomatis. Value Health 2001;4:266-75. http://dx.doi.org/10.1046/j.1524-4733.2001.43009.x
114. Howell MR, Kassler WJ, Haddix A. Partner notification to prevent pelvic inflammatory disease in women. Cost-effectiveness of two strategies. Sex Transm Dis 1997;24:287-92. http://dx.doi.org/10.1097/00007435-199705000-00010
115. Roberts T, Henderson J, Mugford M, Bricker L, Neilson J, Garcia J. Antenatal ultrasound screening for fetal abnormalities: a systematic review of cost and cost effectiveness studies. BJOG 2002;109:44-56. http://dx.doi.org/10.1016/S1470-0328(02)00223-9
116. Institute of Medicine. Vaccines for the 21st Century. A Tool for Decision making. Washington, DC: National Academy Press; 1999.
117. Haggerty CL, Schulz R, Ness RB. Lower quality of life among women with chronic pelvic pain after pelvic inflammatory disease. Obstet Gynecol 2003;102:934-9. http://dx.doi.org/10.1016/S0029-7844(03)00695-1
118. Smith KJ, Tsevat J, Ness RB, Wiesenfeld HC, Roberts MS. Quality of life utilities for pelvic inflammatory disease health states. Sex Transm Dis 2008;35:307-11. http://dx.doi.org/10.1097/OLQ.0b013e31815b07dd
119. Kuppermann M, Learman LA, Schembri M, Gregorich S, Jacoby A, Jackson RA, et al. Effect of noncancerous pelvic problems on health-related quality of life and sexual functioning. Obstet Gynecol 2007;110:633-42. http://dx.doi.org/10.1097/01.AOG.0000279153.56275.b5
120. Mathias SD, Kuppermann M, Liberman RF, Lipschutz RC, Steege JF. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol 1996; 87:321-7. http://dx.doi.org/10.1016/0029-7844(95)00458-0
121. Romão AP, Gorayeb R, Romao GS, Poli-Neto OB, dos Reis FJ, Rosa-e-Silva JC, et al. High levels of anxiety and depression have a negative effect on quality of life of women with chronic pelvic pain. Int J Clin Pract 2009;63:707-11. http://dx.doi.org/10.1111/j.1742-1241.2009.02034.x
122. Haggerty CL, Peipert JF, Weitzen S, Hendrix SL, Holley RL, Nelson DB, et al. Predictors of chronic pelvic pain in an urban population of women with symptoms and signs of pelvic inflammatory disease. Sex Transm Dis 2005;32:293-9. http://dx.doi.org/10.1097/01.olq.0000162361.69041.a5
123. Trent M, Lehmann HP, Qian Q, Thompson CB, Ellen JM, Frick KD. Adolescent and parental utilities for the health states associated with pelvic inflammatory disease. Sex Transm Infect 2011;87:583-7. http://dx.doi.org/10.1136/sextrans-2011-050187
124. Ness RB, Soper DE, Peipert J, Sondheimer SJ, Holley RL, Sweet RL, et al. Design of the PID Evaluation and Clinical Health (PEACH) Study. Control Clin Trials 1998;19:499-514. http://dx.doi.org/10.1016/S0197-2456(98)00022-1
125. Brazier J, Ratcliffe J, Salomon JA, Tsuchiya A. Measuring and Valuing Health Benefits for Economic Evaluation. Oxford: Oxford University Press; 2007.
126. Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI): concepts, measurement properties and applications. Health Qual Life Outcomes 2003;1:54.
127. Torrance GW. Measurement of health state utilities for economic appraisal: a review. J Health Econ 1986;5:1-30.
128. National Institute for Health and Care Excellence. Guide to the Methods of Technology Appraisal. London: National Institute for Health and Care Excellence; 2004. URL: www.nice.org.uk/niceMedia/pdf/TAP_Methods.pdf
129. National Audit Office. Department of Health. Young People's Sexual Health: The National Chlamydia Screening Programme. Report by the Comptroller and Auditor General: HC 963 Session 2008-2009. London: The Stationery Office; 2009. URL: www.nao.org.uk/wp-content/uploads/2009/11/0809963.pdf
130. National Chlamydia Screening Programme. Data Tables. England April 2011-March 2012. 2012. URL: www.chlamydiascreening.nhs.uk/ps/resources/data-tables/CTD-Q1-4-2011_2012.pdf (accessed 6 September 2013).
131. National Chlamydia Screening Programme. Guidance for the Commissioners on the Cost of Providing Chlamydia Screening in Primary Care and the Community: A Review of Costs in Practice Across England in 2009. 2009. URL: www.chlamydiascreening.nhs.uk/ps/resources/guidelines/NCSP_costing_guidance_Dec09.pdf (cited 25 June 2012).
132. National Chlamydia Screening Programme. NHS Vital Signs 2010/11. Primary Care Trust (PCT) and Strategic Health Authority (SHA) Specific Tables. 1st April 2010 to 31st March 2011. 2011. URL: www.chlamydiascreening.nhs.uk/ps/resources/data-tables/VSI_by_PCT_Q1-4_April_2010-March_2011.pdf (cited 28 June 2011).
133. National Chlamydia Screening Programme. NHS Vital Signs 2008/09. Primary Care Trust (PCT) and Strategic Health Authority (SHA) Specific Tables. 1st April 2008 to 31st March 2009. 2009. URL: http://web.archive.org/web/20120430015941/http://www.chlamydiascreening.nhs.uk/ps/assets/pdfs/data/VSI_PCT/Vital_Signs%20_PCT_%20April%2008_Mar%2009_Masked.pdf (cited 28 June 2011).
134. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999;75:3-17. http://dx.doi.org/10.1136/sti.75.1.3
135. Roberts TE, Tsourapas A, Sutcliffe L, Cassell J, Estcourt C. Is Accelerated Partner Therapy (APT) a cost-effective alternative to routine patient referral partner notification in the UK? Preliminary cost-consequence analysis of an exploratory trial. Sex Transm Infect 2012;88:16-20. http://dx.doi.org/10.1136/sextrans-2011-050176
136. Jackson JL, Auguste P, Low N, Roberts TE. Valuing the health states associated with Chlamydia trachomatis infections and their sequelae: a systematic review of economic evaluations and primary studies. Value Health 2014; in press.